Obesity is a predictor in prostate cancer patients receiving prostatectomy after neoadjuvant hormonal therapy
Lijiang Sun(Qingdao University), Guiming Zhang(Qingdao University), Ting Xu(Chengdu University of Traditional Chinese Medicine), Xiaoliang Yuan(Jiangsu University), Dingwei Ye(Fudan University), Feng Liu(Nanjing Chest Hospital), Fengju Guan(Qingdao University)
Cited by 2
Related Papers
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression
|European Urology|2017|202
Rhizosphere effects promote soil aggregate stability and associated organic carbon sequestration in rocky areas of desertification
|Agriculture Ecosystems & Environment|2020|185
Controlled synthesis of ZnO nanowires or nanotubes via sol–gel template process
|Solid State Communications|2005|163